Citations

Mayo Clinic

Clear

2412 citation(s) found for "Yu, Jason".

Common Kibra Alleles Are Associated with Human Memory Performance
Papassotiropoulos, Andreas , Stephan, Dietrich , Huentelman, Matthew J. , Craig, David W. , Pearson, John V. , Huynh, Kim-Dung, Brunner, Fabienne, Corneveaux, Jason J., Osborne, David, Wollmer, M. Axel, Aerni, Amanda , Coluccia, Daniel , Hänggi, Jürgen , Mondadori, Christian R.A., Buchmann, Andreas , Reiman, Eric M. , Caselli, Richard J. , Quervain, Dominique J.‐F. de , Hoerndli, Frédéric J. , Henke, Katharina

Science | October 19, 2006 | Volume: 314 | Issue: 5798 | Pages: 475-478

10.1126/science.1129837 | PMID 17053149 Get It

Human memory is a polygenic trait. We performed a genome-wide screen to identify memory-related gene variants. A genomic locus encoding the brain protein KIBRA was significantly associated with memory performance in three independent, cognitively normal cohorts from Switzerland and the United States. Gene expression studies showed that KIBRA was expressed in memory-related brain structures. Functional magnetic resonance imaging detected KIBRA allele–dependent differences in hippocampal activations during memory retrieval. Evidence from these experiments suggests a role for KIBRA in human memory.
O4–05–01: Methods of cell death and recovery in the rTg4510 and iP301L inducible mouse models of tauopathy
Lewis, Jada , Zehr, Cindy, Andorfer, Cathy, Eriksen, Jason L. , Yue, Mei, Robinson, Todd, Berger, Zdenek , Hanna, Amanda, Janus, Chris, Hutton, Mike, Knight, Joshua A. , Dickson, Dennis W. , McGowan, Eileen

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_3 | Pages: No page available

10.1016/j.jalz.2006.05.327 Get It

P4–196: The capacity of persons with very mild to moderate AD to provide informed consent to enroll in a clinical trial
Karlawish, Jason , vanDyck, Christopher, Marson, Daniel , Kim, Scott Y. H. , Knopman, David S. , James, Bryan D.

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_19 | Pages: No page available

10.1016/j.jalz.2006.05.1935 Get It

P3–293: Tau clearance through protein degradation pathways
Eriksen, Jason L. , Zehr, Cynthia, Berger, Zdenek , Robinson, Todd, Lewis, Jada , Hutton, Michael

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_15 | Pages: No page available

10.1016/j.jalz.2006.05.1562 Get It

P3–163: Identification of a novel risk gene for progressive supranuclear palsy by a genome–wide scan of 500,288 SNPs
Melquist, Stacey , Huentelman, Matthew J. , Craig, David W. , Baker, Matt , Zisman, Victoria L., Gass, Jennifer , Adamson, Jennifer, Szelinger, Szabolcs , Cournevaux, Jason J., Coon, Keith D., Stephan, Dietrich A. , Hutton, Michael , Crook, Richard , Pearson, John V. , Cannon, Ashley , Dickson, Dennis W.

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_14 | Pages: No page available

10.1016/j.jalz.2006.05.1431 Get It

P2–306: Patterns of atrophy in confirmed cases of sporadic and familial Alzheimer's disease: A voxel–based morphometric study
Scahill, Rachael I. , Whitwell, Jennifer L. , Knight, William D., Warren, Jason D. , Godbolt, Alison K. , Schott, Jonathan M. , Rossor, Martin N. , Fox, Nick C.

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_11 | Pages: No page available

10.1016/j.jalz.2006.05.1146 Get It

S2–02–06: The tauopathies: From genetics to animal models
Hutton, Mike, Melquist, Stacey , Zehr, Cynthia, Eriksen, Jason L. , Stephan, Dietrich A. , Lewis, Jada , Baker, Matthew , McGowan, Eileen , Dickson, Dennis W. , Ashe, Karen H.

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_1 | Pages: No page available

10.1016/j.jalz.2006.05.086 Get It

LRRK2 mutations in Parkinson disease
Farrer, Matthew J. , Stone, Jason, Mata, Ignácio F. , Lincoln, S., Kachergus, Jennifer M., Hulihan, Mary , Strain, Kari J., Maraganore, Demetrius M.

Neurology | July 12, 2006 | Volume: 65 | Issue: 5 | Pages: 738-740

10.1212/01.wnl.0000169023.51764.b0 | PMID 16157908 Get It

Vagus nerve stimulation for epilepsy: Randomized comparison of three stimulation paradigms
DeGiorgio, Christopher M. , Heck, Christi, Bunch, S. E., Green, P., Lancman, Martin, Murphy, J. V., Olejniczak, Piotr W., Shih, Jerry J. , Arrambide, Stacey, Soss, Jason, Britton, Jeffrey W.

Neurology | July 12, 2006 | Volume: 65 | Issue: 2 | Pages: 317-319

10.1212/01.wnl.0000168899.11598.00 | PMID 16043810 Get It

An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice
Corre, Sylvie Le, Klafki, Hans‐Wolfgang , Hübinger, Gabriele, Obermeier, Axel, Sahagún, Heidi, Monse, Barbara, Seneci, Pierfausto , Lewis, Jada , Eriksen, Jason L. , Zehr, Cynthia, Yue, Mei, Dickson, Dennis W. , Hutton, Michael , Roder, Hanno M., Plesnila, Nikolaus , McGowan, Eileen , Dickson, Dennis W

Proceedings of the National Academy of Sciences | June 12, 2006 | Volume: 103 | Issue: 25 | Pages: 9673-9678

10.1073/pnas.0602913103 | PMID 16769887 Get It

An orally bioavailable and blood–brain barrier penetrating analog of the kinase inhibitor K252a was able to prevent the typical motor deficits in the tau (P301L) transgenic mouse model (JNPL3) and markedly reduce soluble aggregated hyperphosphorylated tau. However, neurofibrillary tangle counts were not reduced in the successfully treated cohort, suggesting that the main cytotoxic effects of tau are not exerted by neurofibrillary tangles but by lower molecular mass aggregates of tau. Our findings strongly suggest that abnormal tau hyperphosphorylation plays a critical role in the development of tauopathy and suggest a previously undescribed treatment strategy for neurodegenerative diseases involving tau pathology.